← Return to Brinsupri (aka Brensocatib)
Discussion
MAC & Bronchiectasis | Last Active: May 28 3:28pm | Replies (169)
Comment receiving replies
Replies to "@lvnl Here is a different viewpoint to consider. Insurers and Medicare need to control costs when..."
@sueinmn Thanks for spelling that out! I can get that that's how it works. I didn't mean to imply I object to switching to the biosimilar replacement for Humira. It's been well established as just as safe and effective. The cost of Humira is $77,000 annually in the U.S. and far less everywhere else in the world. That's the insane part.
Connect

@sueinmn Would there be consideration for prevention - for the long term advantages of a drug like Brinsupri that reduces inflammation for those with worsening or more severe BE disease, and would presumably reduce risk of hospitalization or more urgent intensive care and other costly antibiotics for patients in the future?
Drug costs are high. It’s a bit shocking to hear the cost of a drug plan in the United States though, relative to other westernized countries.